Literature DB >> 6126380

Dopamine decreases mesenteric blood flow in the anaesthetised dog through the stimulation of postsynaptic alpha 2-adrenoceptors.

N B Shepperson, N Duval, S Z Langer.   

Abstract

The decrease in mesenteric blood flow produced by dopamine administered intra-arterially in the anaesthetised dog was investigated by means of drugs selective for alpha 1- and alpha 2-adrenoceptors. The selective alpha 1-adrenoceptor agonist phenylephrine (0.3-100 microgram) given by intra-arterial injection (i.a.) into the superior mesenteric artery of the anaesthetized dog produced a decrease in mesenteric blood flow which was preferentially blocked by the alpha 1-adrenoceptor antagonist prazosin (30-300 microgram/kg i.v.). On the other hand, i.a. injections of the selective alpha 2-adrenoceptor agonist M7 (1-100 microgram) or of dopamine (1-300 microgram) produced a decrease in mesenteric blood flow which was blocked by the alpha 2-adrenoceptor antagonist yohimbine (100-300 microgram/kg i.v.) but was not significantly reduced by prazosin (300 microgram/kg i.v.). These results demonstrate that the mesenteric vascular bed of the dog contains both alpha 1- and alpha 2-adrenoceptors located postsynaptically and mediating vasoconstriction. The decrease in mesenteric blood flow produced by i.a. injections of dopamine is mediated predominantly via postsynaptic alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6126380     DOI: 10.1016/0014-2999(82)90352-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Presynaptic dopamine DA2-receptors in rabbit jejunal arteries. An electrophysiological study.

Authors:  W Nörenberg; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

2.  Adverse effect of therapeutic vasoconstrictors in experimental acute pancreatitis.

Authors:  E Klar; D W Rattner; C Compton; G Stanford; B Chernow; A L Warshaw
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

3.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

4.  Intrinsic vascular dopamine - a key modulator of hypoxia-induced vasodilatation in splanchnic vessels.

Authors:  Uwe Pfeil; Jitka Kuncova; Doerthe Brüggmann; Renate Paddenberg; Amir Rafiq; Michael Henrich; Markus A Weigand; Klaus-Dieter Schlüter; Marco Mewe; Ralf Middendorff; Jana Slavikova; Wolfgang Kummer
Journal:  J Physiol       Date:  2014-02-17       Impact factor: 5.182

5.  Characterization of alpha-adrenoceptors in the vasculature of the canine nasal mucosa.

Authors:  T L Berridge; A G Roach
Journal:  Br J Pharmacol       Date:  1986-06       Impact factor: 8.739

6.  Renal and iliac vascular effects of dopamine in the anaesthetized rat.

Authors:  M Schmidt; E Giesen-Crouse; J L Imbs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.